These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1514698)

  • 1. The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor.
    Ekholm J; Tatsumi Y; Nouchi T; Hanahan DJ
    Anal Biochem; 1992 Jul; 204(1):79-84. PubMed ID: 1514698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor and sheep platelets: a sensitive new bioassay.
    Moon DG; van der Zee H; Morton KD; Krasodomski JA; Kaplan JE; Fenton JW
    Thromb Res; 1990 Feb; 57(4):551-64. PubMed ID: 2326773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to detect platelet-activating factor using the splenectomized mouse bioassay.
    Scodras JM; Betteridge KJ; Croy BA; Johnstone IB; Rieger D
    J Reprod Fertil; 1991 Jul; 92(2):483-94. PubMed ID: 1886104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a sensitive and specific 14C-serotonin release assay for platelet-activating factor (PAF) in human neutrophils.
    Müller S; Nigam S
    J Lipid Mediat; 1990; 2(6):329-41. PubMed ID: 2133275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.
    Herron D; Dillingham EO; Lyman BA; Zheng X; Bond SE; Salgia SR; Gollamudi R
    Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):309-18. PubMed ID: 7630919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
    Bin Z; Kun L
    Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms.
    Kloprogge E; Akkerman JW
    Biochem J; 1986 Dec; 240(2):403-12. PubMed ID: 3101672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female platelets have distinct functional activity compared with male platelets: Implications in transfusion practice and treatment of trauma-induced coagulopathy.
    Coleman JR; Moore EE; Kelher MR; Samuels JM; Cohen MJ; Sauaia A; Banerjee A; Silliman CC; Peltz ED
    J Trauma Acute Care Surg; 2019 Nov; 87(5):1052-1060. PubMed ID: 31162329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of platelet activating factor on rat platelets in vivo.
    Klee A; Schmid-Schönbein GW; Seiffge D
    Eur J Pharmacol; 1991 Dec; 209(3):223-30. PubMed ID: 1797563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of the binding of platelet-activating factor to platelets of different animal species.
    Iñarrea P; Gomez-Cambronero J; Nieto M; Crespo MS
    Eur J Pharmacol; 1984 Oct; 105(3-4):309-15. PubMed ID: 6510472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modulating effects of adenosine on the process of human platelet activation].
    Prokudin VIu; Melkova OM; Karaulov AV; Porodenko NV
    Biull Eksp Biol Med; 1992 Jun; 113(6):606-8. PubMed ID: 1446028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific, sensitive and high-capacity immunoassay for PAF.
    Baldo BA; Smal MA; McCaskill AC
    Lipids; 1991 Dec; 26(12):1136-9. PubMed ID: 1819700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.
    Bailey SR; Andrews MJ; Elliott J; Cunningham F
    Res Vet Sci; 2000 Apr; 68(2):175-80. PubMed ID: 10756136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions.
    Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J
    Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood.
    Shinozaki K; Kawasaki T; Kambayashi J; Sakon M; Shiba E; Uemura Y; Ou M; Iwamoto N; Mori T
    Life Sci; 1994; 54(6):429-37. PubMed ID: 8295490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
    Burgers JA; Akkerman JW
    J Lipid Mediat; 1992 Sep; 5(3):289-300. PubMed ID: 1334723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of human platelets by platelet activating factor.
    Chesney CM; Pifer DD; Huch KM
    Biochem Biophys Res Commun; 1985 Feb; 127(1):24-30. PubMed ID: 3977920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
    Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.